Free Trial: Direct Access to ValuEngine Research on over 5,000 stocks and 700 ETFs HERE ...

Markets closed the week with measured gains across major equity ETFs, even as geopolitical tensions escalated and volatility expectations rose sharply.

The results indicate that this methodology applied at the end of 2023 resulted in a strong top ten list in 2024. In a year that the Standard & Poor’s SPIVA (S&P vs. Active) blog reported that more ...

Volatility continues to define the early weeks of 2026, with markets swinging back and forth in short one-to-two day cycles. While headline indexes have struggled to establish sustained momentum, ...

ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, ...

ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, ...

ValuEngine lowered its rating on Surgery Partners’ shares from a “hold” to a “sell,” according to The Ledger Gazette. 1. Surgery Partners’ shares opened Nov. 24 trading at $8.60 per share. 2. The ...